Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
10/28/2022 | 60.38% | BTIG | → $0.85 | Initiates Coverage On | → Buy |
MariMed Questions & Answers
The latest price target for MariMed (OTCQX: MRMD) was reported by BTIG on October 28, 2022. The analyst firm set a price target for $0.85 expecting MRMD to rise to within 12 months (a possible 60.38% upside). 1 analyst firms have reported ratings in the last year.
The latest analyst rating for MariMed (OTCQX: MRMD) was provided by BTIG, and MariMed initiated their buy rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of MariMed, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for MariMed was filed on October 28, 2022 so you should expect the next rating to be made available sometime around October 28, 2023.
While ratings are subjective and will change, the latest MariMed (MRMD) rating was a initiated with a price target of $0.00 to $0.85. The current price MariMed (MRMD) is trading at is $0.53, which is within the analyst's predicted range.